- Home
- OPCH vs TFX Comparison
OPCH vs TFX Comparison
Compare OPCH & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPCH
- TFX
- Stock Information
- Founded
- OPCH N/A
- TFX 1943
- Country
- OPCH United States
- TFX United States
- Employees
- OPCH N/A
- TFX N/A
- Industry
- OPCH Medical/Nursing Services
- TFX Medical/Dental Instruments
- Sector
- OPCH Health Care
- TFX Health Care
- Exchange
- OPCH Nasdaq
- TFX Nasdaq
- Market Cap
- OPCH 5.3B
- TFX 5.3B
- IPO Year
- OPCH N/A
- TFX N/A
- Fundamental
- Price
- OPCH $30.68
- TFX $115.77
- Analyst Decision
- OPCH Strong Buy
- TFX Hold
- Analyst Count
- OPCH 7
- TFX 10
- Target Price
- OPCH $35.86
- TFX $176.50
- AVG Volume (30 Days)
- OPCH 1.5M
- TFX 519.7K
- Earning Date
- OPCH 07-30-2025
- TFX 07-31-2025
- Dividend Yield
- OPCH N/A
- TFX 1.18%
- EPS Growth
- OPCH N/A
- TFX N/A
- EPS
- OPCH 1.25
- TFX 3.20
- Revenue
- OPCH $5,185,122,000.00
- TFX $3,010,144,000.00
- Revenue This Year
- OPCH $13.22
- TFX $2.98
- Revenue Next Year
- OPCH $8.52
- TFX $4.72
- P/E Ratio
- OPCH $24.44
- TFX $36.36
- Revenue Growth
- OPCH 16.98
- TFX 0.29
- 52 Week Low
- OPCH $21.39
- TFX $114.85
- 52 Week High
- OPCH $35.53
- TFX $249.91
- Technical
- Relative Strength Index (RSI)
- OPCH 43.18
- TFX 39.63
- Support Level
- OPCH $29.79
- TFX $116.32
- Resistance Level
- OPCH $31.22
- TFX $121.75
- Average True Range (ATR)
- OPCH 0.67
- TFX 2.82
- MACD
- OPCH -0.13
- TFX -0.08
- Stochastic Oscillator
- OPCH 32.48
- TFX 13.36
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.